These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34821191)

  • 1. Blood eosinophils in COPD: friend or foe?
    Papaporfyriou A; Bakakos P; Hillas G; Papaioannou AI; Loukides S
    Expert Rev Respir Med; 2022 Jan; 16(1):35-41. PubMed ID: 34821191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait.
    David B; Bafadhel M; Koenderman L; De Soyza A
    Thorax; 2021 Feb; 76(2):188-195. PubMed ID: 33122447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic COPD - a distinct phenotype of the disease.
    Tworek D; Antczak A
    Adv Respir Med; 2017; 85(5):271-276. PubMed ID: 29083023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality.
    Zhang Y; Liang LR; Zhang S; Lu Y; Chen YY; Shi HZ; Lin YX
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1123-1134. PubMed ID: 32547000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD.
    Kostikas K; Brindicci C; Patalano F
    Curr Drug Targets; 2018; 19(16):1882-1896. PubMed ID: 29437007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Blood Eosinophils in the Management of COPD: An Attempt to Answer the Important Clinical Questions.
    Bartziokas K; Gogali A; Kostikas K
    COPD; 2021 Dec; 18(6):690-699. PubMed ID: 34657541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Eosinophilic chronic obstructive pulmonary disease: A review].
    Anaev EK
    Ter Arkh; 2023 Oct; 95(8):696-700. PubMed ID: 38158908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophils in COPD-Current Concepts and Clinical Implications.
    Mycroft K; Krenke R; Górska K
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2565-2574. PubMed ID: 32251737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
    Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
    COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma.
    Li A; Chan HP; Gan PXL; Liew MF; Wong WSF; Lim HF
    Korean J Intern Med; 2021 Nov; 36(6):1305-1319. PubMed ID: 34634855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic obstructive pulmonary disease (COPD): eosinophilia and novel drug therapies].
    Biener L; Pizarro C; Skowasch D
    Inn Med (Heidelb); 2024 Jul; 65(7):738-745. PubMed ID: 38831048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions.
    Couillard S; Larivée P; Courteau J; Vanasse A
    Chest; 2017 Feb; 151(2):366-373. PubMed ID: 27746201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD.
    Bafadhel M; Greening NJ; Harvey-Dunstan TC; Williams JE; Morgan MD; Brightling CE; Hussain SF; Pavord ID; Singh SJ; Steiner MC
    Chest; 2016 Aug; 150(2):320-8. PubMed ID: 26851799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations.
    Gao J; Chen B; Wu S; Wu F
    BMC Pulm Med; 2020 Feb; 20(1):50. PubMed ID: 32093672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease.
    Zeiger RS; Tran TN; Butler RK; Schatz M; Li Q; Khatry DB; Martin U; Kawatkar AA; Chen W
    J Allergy Clin Immunol Pract; 2018; 6(3):944-954.e5. PubMed ID: 29153881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophils in COPD: just another biomarker?
    Bafadhel M; Pavord ID; Russell REK
    Lancet Respir Med; 2017 Sep; 5(9):747-759. PubMed ID: 28601554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute Blood Eosinophil Counts to Guide Inhaled Corticosteroids Therapy Among Patients with COPD: Systematic Review and Meta-analysis.
    Oshagbemi OA; Odiba JO; Daniel A; Yunusa I
    Curr Drug Targets; 2019; 20(16):1670-1679. PubMed ID: 31393244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis.
    Cheng SL
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2775-2784. PubMed ID: 30233168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population.
    Vestbo J; Vogelmeier CF; Small M; Siddall J; Fogel R; Kostikas K
    Int J Chron Obstruct Pulmon Dis; 2019; 14():853-861. PubMed ID: 31114183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.